Welcome to our dedicated page for Wearable Devices SEC filings (Ticker: WLDSW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wearable Devices Ltd. SEC filings document the company’s foreign private issuer disclosures, business updates, and capital structure for its Nasdaq-listed ordinary shares and tradable warrants. Form 6-K reports include financial results, Mudra product and commercialization updates, equity financing activity, and material-event disclosures tied to its AI-powered touchless sensing wearables business.
The filing record also covers security-structure matters such as reverse share split disclosures, warrant adjustments, Nasdaq listing compliance, shareholder voting matters, and authorized share capital. Governance and compensation-related filings include updates to the company’s 2024 Global Equity Incentive Plan and incorporation of Form 6-K reports into Form S-8 and Form F-3 registration statements.
Wearable Devices Ltd. filed an initial ownership report for Chief Technology Officer Langer Leeor Jacob. He directly holds 72,917 Ordinary Shares and stock options to acquire 125 additional Ordinary Shares at an exercise price of 316.8 per share, expiring on August 23, 2033.
The filing notes 6,250 Ordinary Shares issuable upon vesting of restricted share units in equal monthly installments of 1,042 shares through September 10, 2026, and 47,222 Ordinary Shares issuable upon vesting of restricted share units in equal monthly installments of 1,389 shares through January 1, 2029.
Wearable Devices Ltd. filed an initial ownership report for Chief Technology Officer Langer Leeor Jacob. He directly holds 72,917 Ordinary Shares and stock options to acquire 125 additional Ordinary Shares at an exercise price of 316.8 per share, expiring on August 23, 2033.
The filing notes 6,250 Ordinary Shares issuable upon vesting of restricted share units in equal monthly installments of 1,042 shares through September 10, 2026, and 47,222 Ordinary Shares issuable upon vesting of restricted share units in equal monthly installments of 1,389 shares through January 1, 2029.
Wearable Devices Ltd. executive Remez Offir has filed an initial Form 3 showing his equity holdings in the company. The filing reports direct ownership of 25,417 Ordinary Shares as of the reporting date, establishing his baseline stake as Executive VP of Business Development.
Offir also holds stock options over 571 Ordinary Shares at an exercise price of $0.72 per share expiring on November 1, 2031, and options over 83 Ordinary Shares at an exercise price of $316.80 per share expiring on November 30, 2033. Footnotes indicate additional equity incentives through restricted share units: 2,500 Ordinary Shares vesting in equal monthly installments of 417 shares through September 10, 2026, and 16,528 Ordinary Shares vesting in equal monthly installments of 486 shares through January 1, 2029, with each RSU convertible into one Ordinary Share.
Wearable Devices Ltd. executive Remez Offir has filed an initial Form 3 showing his equity holdings in the company. The filing reports direct ownership of 25,417 Ordinary Shares as of the reporting date, establishing his baseline stake as Executive VP of Business Development.
Offir also holds stock options over 571 Ordinary Shares at an exercise price of $0.72 per share expiring on November 1, 2031, and options over 83 Ordinary Shares at an exercise price of $316.80 per share expiring on November 30, 2033. Footnotes indicate additional equity incentives through restricted share units: 2,500 Ordinary Shares vesting in equal monthly installments of 417 shares through September 10, 2026, and 16,528 Ordinary Shares vesting in equal monthly installments of 486 shares through January 1, 2029, with each RSU convertible into one Ordinary Share.
Wearable Devices Ltd. director Ilana Lurie filed an initial ownership report showing her equity stake in the company. She directly holds 37,500 Ordinary Shares. This amount includes 7,500 shares issuable from 2,500 restricted share units (RSUs) that begin vesting on October 10, 2026 and then in equal monthly installments through October 10, 2028, and 28,333 shares issuable from RSUs vesting in equal monthly installments of 833 shares through January 1, 2029, with each RSU representing one Ordinary Share.
She also holds a stock option covering 83 Ordinary Shares at an exercise price of 316.8000, which was granted on November 30, 2023, vests in monthly installments after an initial vesting on August 23, 2024, and expires on November 30, 2033.
Wearable Devices Ltd. director Ilana Lurie filed an initial ownership report showing her equity stake in the company. She directly holds 37,500 Ordinary Shares. This amount includes 7,500 shares issuable from 2,500 restricted share units (RSUs) that begin vesting on October 10, 2026 and then in equal monthly installments through October 10, 2028, and 28,333 shares issuable from RSUs vesting in equal monthly installments of 833 shares through January 1, 2029, with each RSU representing one Ordinary Share.
She also holds a stock option covering 83 Ordinary Shares at an exercise price of 316.8000, which was granted on November 30, 2023, vests in monthly installments after an initial vesting on August 23, 2024, and expires on November 30, 2033.
Wearable Devices Ltd. director Nir Yaacov filed an initial insider ownership report on Form 3. The filing lists him as a director of the company but does not report any share transactions or derivative positions, indicating this is a baseline disclosure rather than a trading event.
Wearable Devices Ltd. director Nir Yaacov filed an initial insider ownership report on Form 3. The filing lists him as a director of the company but does not report any share transactions or derivative positions, indicating this is a baseline disclosure rather than a trading event.
Wearable Devices Ltd. Chief Financial Officer Mualem Alon filed an initial Form 3 reporting his existing equity position. He directly holds 52,083 Ordinary Shares and has stock options covering 417 shares at an exercise price of $0.7200 expiring on January 23, 2032 and 83 shares at $316.8000 expiring on November 30, 2033. Footnotes also describe RSU awards for 5,000 Ordinary Shares vesting monthly through September 10, 2026 and 37,778 Ordinary Shares vesting monthly through January 1, 2029, each RSU representing one Ordinary Share.
Wearable Devices Ltd. Chief Financial Officer Mualem Alon filed an initial Form 3 reporting his existing equity position. He directly holds 52,083 Ordinary Shares and has stock options covering 417 shares at an exercise price of $0.7200 expiring on January 23, 2032 and 83 shares at $316.8000 expiring on November 30, 2033. Footnotes also describe RSU awards for 5,000 Ordinary Shares vesting monthly through September 10, 2026 and 37,778 Ordinary Shares vesting monthly through January 1, 2029, each RSU representing one Ordinary Share.
Wearable Devices Ltd. Chief Operating Officer Tamar Fleisher filed an initial ownership report showing direct holdings in the company’s ordinary shares and equity awards. The filing lists 23,667 Ordinary Shares, which include RSUs for 2,500 shares vesting in monthly installments of 417 shares through September 10, 2026 and RSUs for 16,056 shares vesting in monthly installments of 472 shares through January 1, 2029. Fleisher also holds stock options over 125 ordinary shares at an exercise price of 158.4000, expiring on December 15, 2032, and options over 63 ordinary shares at an exercise price of 316.8000, expiring on November 30, 2033. These entries reflect existing positions rather than new market purchases or sales.
Wearable Devices Ltd. Chief Operating Officer Tamar Fleisher filed an initial ownership report showing direct holdings in the company’s ordinary shares and equity awards. The filing lists 23,667 Ordinary Shares, which include RSUs for 2,500 shares vesting in monthly installments of 417 shares through September 10, 2026 and RSUs for 16,056 shares vesting in monthly installments of 472 shares through January 1, 2029. Fleisher also holds stock options over 125 ordinary shares at an exercise price of 158.4000, expiring on December 15, 2032, and options over 63 ordinary shares at an exercise price of 316.8000, expiring on November 30, 2033. These entries reflect existing positions rather than new market purchases or sales.
Wearable Devices Ltd. reported full-year 2025 results showing early revenue growth but continued losses. Revenue rose to $647 thousand from $522 thousand, helped by a 28.5% increase in sales of its Mudra Link and Mudra Band gesture-control products.
The company remained unprofitable, with an operating loss of $8.3 million and a net loss of $8.1 million. During 2025 it raised approximately $24.4 million in gross proceeds from equity offerings, ending the year with a cash balance of $6.5 million and short-term deposits of $11.9 million, for total current assets of $19.5 million. Total liabilities fell to $1.4 million after repaying a convertible note, and shareholders’ equity increased to $18.6 million.
Wearable Devices Ltd. reported full-year 2025 results showing early revenue growth but continued losses. Revenue rose to $647 thousand from $522 thousand, helped by a 28.5% increase in sales of its Mudra Link and Mudra Band gesture-control products.
The company remained unprofitable, with an operating loss of $8.3 million and a net loss of $8.1 million. During 2025 it raised approximately $24.4 million in gross proceeds from equity offerings, ending the year with a cash balance of $6.5 million and short-term deposits of $11.9 million, for total current assets of $19.5 million. Total liabilities fell to $1.4 million after repaying a convertible note, and shareholders’ equity increased to $18.6 million.
Wearable Devices Ltd. is carrying out a 1‑for‑3 reverse share split of its ordinary shares and publicly traded warrants. Every three existing shares or warrants will be consolidated into one, with warrant exercise prices adjusted proportionally.
The move aims to increase the share price to help regain compliance with Nasdaq’s $1.00 minimum bid requirement and protect the company’s continued listing on the Nasdaq Capital Market. After the split, issued and outstanding ordinary shares will be reduced from 10,593,227 to approximately 3,531,076, and publicly held warrants from 98,589 to approximately 32,863, while authorized capital remains at 500,000,000 shares.
The split, approved by shareholders and the board at a 1‑for‑3 ratio, will take effect for trading on a split‑adjusted basis when the market opens on March 11, 2026. Fractional positions will be rounded to the nearest whole share or warrant, and outstanding equity awards and plan reserves will be adjusted proportionally.
Wearable Devices Ltd. is carrying out a 1‑for‑3 reverse share split of its ordinary shares and publicly traded warrants. Every three existing shares or warrants will be consolidated into one, with warrant exercise prices adjusted proportionally.
The move aims to increase the share price to help regain compliance with Nasdaq’s $1.00 minimum bid requirement and protect the company’s continued listing on the Nasdaq Capital Market. After the split, issued and outstanding ordinary shares will be reduced from 10,593,227 to approximately 3,531,076, and publicly held warrants from 98,589 to approximately 32,863, while authorized capital remains at 500,000,000 shares.
The split, approved by shareholders and the board at a 1‑for‑3 ratio, will take effect for trading on a split‑adjusted basis when the market opens on March 11, 2026. Fractional positions will be rounded to the nearest whole share or warrant, and outstanding equity awards and plan reserves will be adjusted proportionally.
Wearable Devices Ltd. reported that its Board of Directors approved an increase in the number of ordinary shares reserved for its 2024 Global Equity Incentive Plan. The reserve rose by 1,431,713 shares, from 2,473,856 to 3,905,569 ordinary shares.
This change expands the pool of shares available for future equity-based awards to employees, directors, and other eligible participants under the plan. The report is also incorporated by reference into the company’s existing Form S-8 and Form F-3 registration statements.
Wearable Devices Ltd. reported that its Board of Directors approved an increase in the number of ordinary shares reserved for its 2024 Global Equity Incentive Plan. The reserve rose by 1,431,713 shares, from 2,473,856 to 3,905,569 ordinary shares.
This change expands the pool of shares available for future equity-based awards to employees, directors, and other eligible participants under the plan. The report is also incorporated by reference into the company’s existing Form S-8 and Form F-3 registration statements.
Wearable Devices Ltd. held a special shareholder meeting where a quorum was reached after an adjournment and all seven proposals were approved. A key outcome was adoption of an amended and restated compensation policy for executives and directors.
The updated policy increases the chief executive officer’s maximum base salary and raises annual bonus caps. It also revises the mix between fixed and variable pay by role, expands equity-based compensation limits for office holders, and increases the maximum annual equity grants for directors. The detailed policy, dated September 2025, is attached as an exhibit and will govern salaries, bonuses, equity awards, change-of-control treatment and clawback mechanisms for the company’s office holders.
Wearable Devices Ltd. held a special shareholder meeting where a quorum was reached after an adjournment and all seven proposals were approved. A key outcome was adoption of an amended and restated compensation policy for executives and directors.
The updated policy increases the chief executive officer’s maximum base salary and raises annual bonus caps. It also revises the mix between fixed and variable pay by role, expands equity-based compensation limits for office holders, and increases the maximum annual equity grants for directors. The detailed policy, dated September 2025, is attached as an exhibit and will govern salaries, bonuses, equity awards, change-of-control treatment and clawback mechanisms for the company’s office holders.